FDA approves tool for tricuspid regurgitation, offering minimally invasive option

A new form of technology that is designed to improve heart function through a tool that provides a transcatheter edge-to-edge ...

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial

Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to initiate its nPulse Cardiac Catheter Ablation System study for the treatment of ...
TipRanks on MSN

Imricor adds Charité as second global site for VISABL-VT MRI-guided ablation trial

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

How Untreated Varicose Veins Can Lead to Leg Ulcers, Clots, and Skin Damage]

Understanding Varicose Veins Varicose veins arise from a chronic circulatory disorder called chronic venous insufficiency ...
Le Lézard

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences, Inc. , a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced that the U.S.